N-Nitrosoguvacine
CAS: 55557-01-2
Ref. 3D-FCA55701
1mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
500mg | Discontinued |
Product Information
- 1-Nitroso-1,2,5,6-tetrahydropyridine-3-carboxylic acid
- 3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-nitroso-
- 1,2,5,6-Tetrahydro-1-nitroso-3-pyridinecarboxylic acid
- Nitrosoguvacine
N-Nitrosoguvacine is a genotoxic carcinogen that is used for the treatment of cancer. It is an orally administered drug that is metabolized in the liver to its active form, N-nitrosoureido guanine. N-Nitrosoguvacine has been shown to cause cancer in humans and animals. This agent also causes DNA methylation, which can lead to cell death and tumor development.